scholarly article | Q13442814 |
P356 | DOI | 10.1016/S1368-8375(98)00068-2 |
P698 | PubMed publication ID | 9930359 |
P2093 | author name string | G M McCarthy | |
M Vincent | |||
W I Kocha | |||
H Ghandi | |||
J D Awde | |||
P2860 | cites work | Orofacial complications of chemotherapy for breast cancer | Q28326692 |
Toxicity and response criteria of the Eastern Cooperative Oncology Group | Q29619399 | ||
Reporting results of cancer treatment | Q29620070 | ||
Combination chemotherapy with cisplatin and 5-fluorouracil 5-day infusion in the therapy of advanced gastric cancer: A Phase II trial | Q33377409 | ||
An early phase II study of 5-fluorouracil combined with cisplatinum as a second line chemotherapy against metastatic gastric cancer. | Q33391080 | ||
Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer | Q33488159 | ||
High-dose, brief duration, multiagent chemotherapy for metastatic breast cancer | Q33492422 | ||
Radiation-induced xerostomia in cancer patients.Effect on salivary and serum electrolytes | Q39102622 | ||
Treatment of radiation- and chemotherapy-induced stomatitis | Q39518299 | ||
Fluorouracil: biochemistry and pharmacology | Q39527807 | ||
Xerostomia: Diagnosis and treatment | Q40159396 | ||
Oral complications in patients receiving treatment for malignancies other than of the head and neck | Q40557148 | ||
Relationship of oral complications to peripheral blood leukocyte and platelet counts in patients receiving cancer chemotherapy | Q40716256 | ||
Periodontal infection in patients with acute nonlymphocyte leukemia. Prevalence of acute exacerbations | Q40846087 | ||
Physiological aspects of aging. Implications for the treatment of cancer | Q40931106 | ||
Studies of oral neutrophil levels in patients receiving G‐CSF after autologous marrow transplantation | Q41079186 | ||
A comparative study of herpes simplex infections in renal transplant and leukemic patients | Q42058885 | ||
Cancer statistics, 1995. | Q43686273 | ||
Oral mucosal status and major salivary gland function. | Q44922190 | ||
A long-term prospective clinical study of orofacial herpes simplex virus infection in acute leukemia | Q45831016 | ||
Biochemical basis for fluorouracil neurotoxicity. The role of Krebs cycle inhibition by fluoroacetate | Q48906248 | ||
The Functions of Saliva | Q55892987 | ||
Weekly high-dose infusion of 5-fluorouracil in advanced colorectal cancer | Q61917339 | ||
Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy | Q67482465 | ||
Randomised comparison of weekly bolus 5-fluorouracil with or without leucovorin in metastatic colorectal carcinoma | Q67549025 | ||
Xerostomia. Part I: Relationship to other oral symptoms and salivary gland hypofunction | Q67960755 | ||
Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized double-blind trial | Q68497740 | ||
Neutropenic ulceration. A distinctive clinical entity | Q68749435 | ||
Clinical characteristics and mechanisms involved in chemotherapy-induced oral ulceration | Q68758707 | ||
Variables predicting oral mucosal lesions in allogenic bone marrow recipients | Q70163687 | ||
Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable rectal cancer | Q70670951 | ||
Chemotherapy-induced oral mucositis in adult leukemia | Q71450733 | ||
Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience | Q71613641 | ||
Effect of granulocyte colony-stimulating factor (G-CSF) on chemotherapy-induced oral mucositis | Q71705617 | ||
Prophylaxis of oral mucositis associated with chemoradiotherapy for oral carcinoma by Azelastine hydrochloride (Azelastine) with other antioxidants | Q72120609 | ||
Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinoma | Q72520138 | ||
Effect of intravenous hyperalimentation and oral care on the development of oral stomatitis during cancer chemotherapy | Q72657060 | ||
A phase I/II trial of twice daily irradiation and concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neck | Q72680240 | ||
Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial | Q72732640 | ||
Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil-induced stomatitis | Q72780566 | ||
P433 | issue | 6 | |
P921 | main subject | fluorouracil | Q238512 |
P304 | page(s) | 484-490 | |
P577 | publication date | 1998-11-01 | |
P1433 | published in | Oral Oncology | Q7099367 |
P1476 | title | Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil | |
P478 | volume | 34 |
Q52560942 | A Review of Clinical Radioprotection and Chemoprotection for Oral Mucositis. |
Q43844206 | A pilot study evaluating the safety and microbiologic efficacy of an economically viable antimicrobial lozenge in patients with head and neck cancer receiving radiation therapy |
Q40254265 | A survey of National Cancer Institute-designated comprehensive cancer centers' oral health supportive care practices and resources in the USA. |
Q34403510 | Adverse event management of oral mucositis in patients with breast cancer |
Q35867296 | Analysis of the influence of parenteral cancer chemotherapy on the health condition of oral mucosa |
Q57065023 | Anthocyanins Extracted from L. Prevent Fluorouracil-Induced Nuclear Factor-κB Activation in Oral Mucositis: In Vitro and In Vivo Studies |
Q40741211 | Atorvastatin and trans-caryophyllene for the prevention of leukopenia in an experimental chemotherapy model in Wistar rats |
Q46059347 | Characteristics and risk factors of oral mucositis after allogeneic stem cell transplantation with FLU/MEL conditioning regimen in context with BU/CY2. |
Q34087232 | Chemotherapy-induced oral mucositis. Prevention and management |
Q35219131 | Drug effects on salivary glands: dry mouth |
Q55709896 | Elemental Diet Accelerates the Recovery From Oral Mucositis and Dermatitis Induced by 5-Fluorouracil Through the Induction of Fibroblast Growth Factor 2. |
Q36458432 | Emerging approaches for prophylaxis and management of oropharyngeal mucositis in cancer therapy |
Q33874148 | Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: An informative gene network analysis |
Q38833088 | Influence of an elemental diet on 5-fluorouracil-induced morphological changes in the mouse salivary gland and colon |
Q87423296 | Low body mass index as a risk factor of moderate to severe oral mucositis in oral cancer patients with radiotherapy |
Q36494114 | Management of oral mucositis in patients who have cancer |
Q92941250 | Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside |
Q34317762 | Mucositis and salivary antioxidants in patients undergoing bone marrow transplantation (BMT) |
Q64100060 | Oral Health Status and Oral Health-related Quality of Life According to Presence or Absence of Mucositis in Head and Neck Cancer Patients |
Q33195001 | Oral and intestinal mucositis — causes and possible treatments |
Q46539342 | Oral mucosal lesions, microbial changes, and taste disturbances induced by adjuvant chemotherapy in breast cancer patients |
Q51503216 | Prevalence of clinically relevant oral mucositis in outpatients receiving myelosuppressive chemotherapy for solid tumors. |
Q37554896 | Prevention and management of adverse events related to regorafenib |
Q37454779 | Preventive effect of rebamipide gargle on chemoradiotherpy-induced oral mucositis in patients with oral cancer: a pilot study |
Q79611039 | Probiotic effects on 5-fluorouracil-induced mucositis assessed by the sucrose breath test in rats |
Q84349532 | Prospective evaluation of oral mucositis in acute leukemia patients receiving chemotherapy |
Q36965711 | Radiation therapy and chemotherapy-induced oral mucositis |
Q45254400 | Randomized controlled trial of pilocarpine hydrochloride for the moderation of oral mucositis during autologous blood stem cell transplantation |
Q34070317 | Risk factors determining chemotherapeutic toxicity in patients with advanced colorectal cancer |
Q33260759 | Risk factors for oral mucositis in paediatric oncology patients receiving alkylant chemotherapy |
Q35037721 | Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions |
Q40337532 | The impact of oral herpes simplex virus infection and candidiasis on chemotherapy-induced oral mucositis among patients with hematological malignancies. |